Gamma Medica has agreed to exclusively license an enhancement package for Exxim's COBRA reconstruction code. Gamma Medica supplies the conebeam reconstruction code with its X-SPECT preclinical imaging system, which medical researchers and drug companies
Gamma Medica has agreed to exclusively license an enhancement package for Exxim's COBRA reconstruction code. Gamma Medica supplies the conebeam reconstruction code with its X-SPECT preclinical imaging system, which medical researchers and drug companies use to conduct in vivo imaging studies of molecular markers. The X-SPECT system combines the functional nuclear medicine SPECT technique with anatomical imaging provided by x-ray CT.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.